Associate Scientist, DST at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor's degree in Biotechnology, Cell Biology or related field with a minimum of 6 years of relevant industry experience OR Master's degree with at least 3 years of relevant industry experience (Preferred)
Basic Qualifications: 4+ Years with BS OR 2+ Years with MS
Proficiency in cell biology and in vitro pharmacology techniques, including, but not limited to, mammalian cell culture, flow cytometry, and cell-based assays (Preferred)
Research experience in antibody drug discovery for oncology or fibrosis (Preferred)
Experience with automation (implied from responsibilities)

Responsibilities

Independently conceive, develop, optimize, execute, and troubleshoot in-vitro plate-based assays to support large and/or small molecule drug discovery efforts; may contribute to technical sections of reports and publications
Apply increased depth or breadth of assay technologies in generating experimental data to support projects technically from start to finish
Apply and use lab automation and liquid handlers to screen and profile large and small molecules for hit identification and lead optimization across diverse therapeutic modalities
Perform mechanistic studies to elucidate mode of action for lead molecules
Evaluate and implement novel assay technologies to support advancement of internal programs and core platform functions
Contribute to multiple concurrent projects, collaborate effectively within cross-functional teams
Effectively communicate scientific findings clearly and concisely, both verbally and in writing. Interpret experimental outcomes and present results in project team meetings
Serve as a technical resource within DST for assay or inventory workflows. Train junior group members with instruments and technical aspects of experiments

Skills

biochemical assays

biophysical assays

cellular assays

small molecule

biologics

drug discovery

in vitro assays

medicinal chemistry

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free